These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 11545616

  • 1. A novel approach to cancer therapy using an oncolytic herpes virus to package amplicons containing cytokine genes.
    Carew JF, Kooby DA, Halterman MW, Kim SH, Federoff HJ, Fong Y.
    Mol Ther; 2001 Sep; 4(3):250-6. PubMed ID: 11545616
    [Abstract] [Full Text] [Related]

  • 2. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
    Zager JS, Delman KA, Malhotra S, Ebright MI, Bennett JJ, Kates T, Halterman M, Federoff H, Fong Y.
    Mol Med; 2001 Aug; 7(8):561-8. PubMed ID: 11591892
    [Abstract] [Full Text] [Related]

  • 3. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic virus therapy using genetically engineered herpes simplex viruses.
    Todo T.
    Front Biosci; 2008 Jan 01; 13():2060-4. PubMed ID: 17981691
    [Abstract] [Full Text] [Related]

  • 5. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
    Wong RJ, Patel SG, Kim S, DeMatteo RP, Malhotra S, Bennett JJ, St-Louis M, Shah JP, Johnson PA, Fong Y.
    Hum Gene Ther; 2001 Feb 10; 12(3):253-65. PubMed ID: 11177562
    [Abstract] [Full Text] [Related]

  • 6. Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.
    Coukos G, Makrigiannakis A, Montas S, Kaiser LR, Toyozumi T, Benjamin I, Albelda SM, Rubin SC, Molnar-Kimber KL.
    Cancer Gene Ther; 2000 Feb 10; 7(2):275-83. PubMed ID: 10770637
    [Abstract] [Full Text] [Related]

  • 7. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K, Wakimoto H, Tyminski E, Chiocca EA, Saeki Y.
    Gene Ther; 2006 Apr 10; 13(8):705-14. PubMed ID: 16421599
    [Abstract] [Full Text] [Related]

  • 8. Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
    Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F.
    Cancer Lett; 2010 Feb 01; 288(1):17-27. PubMed ID: 19604626
    [Abstract] [Full Text] [Related]

  • 9. Comparison of safety, delivery, and efficacy of two oncolytic herpes viruses (G207 and NV1020) for peritoneal cancer.
    Bennett JJ, Delman KA, Burt BM, Mariotti A, Malhotra S, Zager J, Petrowsky H, Mastorides S, Federoff H, Fong Y.
    Cancer Gene Ther; 2002 Nov 01; 9(11):935-45. PubMed ID: 12386832
    [Abstract] [Full Text] [Related]

  • 10. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
    Toda M, Iizuka Y, Kawase T, Uyemura K, Kawakami Y.
    Cancer Gene Ther; 2002 Apr 01; 9(4):356-64. PubMed ID: 11960286
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors.
    Todo T, Rabkin SD, Martuza RL.
    Cancer Gene Ther; 2000 Jun 01; 7(6):939-46. PubMed ID: 10880026
    [Abstract] [Full Text] [Related]

  • 12. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck.
    Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG, Shah JP, Fong Y.
    Eur J Cancer; 2005 Jan 01; 41(2):313-22. PubMed ID: 15661558
    [Abstract] [Full Text] [Related]

  • 13. Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.
    Chahlavi A, Todo T, Martuza RL, Rabkin SD.
    Neoplasia; 1999 Jun 01; 1(2):162-9. PubMed ID: 10933051
    [Abstract] [Full Text] [Related]

  • 14. Enhanced efficacy of conditionally replicating herpes simplex virus (G207) combined with 5-fluorouracil and surgical resection in peritoneal cancer dissemination models.
    Nakano K, Todo T, Zhao G, Yamaguchi K, Kuroki S, Cohen JB, Glorioso JC, Tanaka M.
    J Gene Med; 2005 May 01; 7(5):638-48. PubMed ID: 15754306
    [Abstract] [Full Text] [Related]

  • 15. Corticosteroid administration does not affect viral oncolytic activity, but inhibits antitumor immunity in replication-competent herpes simplex virus tumor therapy.
    Todo T, Rabkin SD, Chahlavi A, Martuza RL.
    Hum Gene Ther; 1999 Nov 20; 10(17):2869-78. PubMed ID: 10584932
    [Abstract] [Full Text] [Related]

  • 16. Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation.
    Blank SV, Rubin SC, Coukos G, Amin KM, Albelda SM, Molnar-Kimber KL.
    Hum Gene Ther; 2002 Mar 20; 13(5):627-39. PubMed ID: 11916486
    [Abstract] [Full Text] [Related]

  • 17. Targeted oncolytic herpes simplex viruses for aggressive cancers.
    Wong J, Lee C, Zhang K, Rennie PS, Jia W.
    Curr Pharm Biotechnol; 2012 Jul 20; 13(9):1786-94. PubMed ID: 21740360
    [Abstract] [Full Text] [Related]

  • 18. Immunogenic HSV-mediated oncolysis shapes the antitumor immune response and contributes to therapeutic efficacy.
    Workenhe ST, Simmons G, Pol JG, Lichty BD, Halford WP, Mossman KL.
    Mol Ther; 2014 Jan 20; 22(1):123-31. PubMed ID: 24343053
    [Abstract] [Full Text] [Related]

  • 19. Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.
    Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.
    Cancer Gene Ther; 2000 Sep 20; 7(9):1279-85. PubMed ID: 11023201
    [Abstract] [Full Text] [Related]

  • 20. Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
    Cinatl J, Cinatl J, Michaelis M, Kabickova H, Kotchetkov R, Vogel JU, Doerr HW, Klingebiel T, Driever PH.
    Cancer Res; 2003 Apr 01; 63(7):1508-14. PubMed ID: 12670897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.